top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
43063-0876-04 | Q0169 | PROMETHAZINE HYDROCHLORIDE, 12.5 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN | PROMETHAZINE HCL 50 MG | PO |
43063-0911-21 | J7512 | PREDNISONE, IMMEDIATE RELEASE OR DELAYED RELEASE, ORAL, 1 MG | PREDNISONE 20 MG | PO |
43066-0001-01 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (1X2ML,MDV) 10 MG/1 ML | IV |
43066-0006-01 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (1X8ML,MDV) 10 MG/1 ML | IV |
43066-0010-01 | J9171 | INJECTION, DOCETAXEL, 1 MG | DOCETAXEL (1X2ML,MDV) 10 MG/1 ML | IV |
43066-0014-01 | J9263 | INJECTION, OXALIPLATIN, 0.5 MG | OXALIPLATIN (PF) 5 MG/1 ML | IV |
43066-0015-10 | J2795 | INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG | ROPIVACAINE HCL (10X20ML;SDV;USP,PF) 2 MG/1 ML | IJ |
43066-0018-01 | J9263 | INJECTION, OXALIPLATIN, 0.5 MG | OXALIPLATIN (PF) 5 MG/1 ML | IV |
43066-0019-10 | J2795 | INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG | ROPIVACAINE HCL (10X20ML;SDV;USP,PF) 5 MG/1 ML | IJ |
43066-0023-10 | J2795 | INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG | ROPIVACAINE HCL (10X30ML;SDV;USP,PF) 5 MG/1 ML | IJ |
43066-0027-10 | J2795 | INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG | ROPIVACAINE HCL (10X20ML;SDV;USP,PF) 10 MG/1 ML | IJ |
43066-0090-25 | J0780 | INJECTION, PROCHLORPERAZINE, UP TO 10 MG | PROCHLORPERAZINE EDISYLATE 5 MG/1 ML | IJ |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
